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To the Editor
Dr Adashi and Senator Wyden (D-OR) commented on the Centers for Disease Control and 
Prevention’s (CDC’s) National Assisted Reproductive Technology Surveillance System 
(NASS).1 The Society for Assisted Reproductive Technology started collecting assisted 
reproductive technology (ART) data from member-clinics in 1986; the CDC has been 
collecting detailed information on all ART procedures performed annually in the United 
States since 1995 and has been monitoring ART effectiveness and safety.
Several factors contribute to the high quality of surveillance data, including support of 
professional societies and consumer organizations, as well as annual data validation of a 
sample of ART programs. However, there are areas for improvement. Currently, ART 
programs submit their data to the CDC 1 year after the end of the reporting year to allow 
collection of complete information about births following successful ART procedures. 
Another year is needed for statistical analyses, preparation, and publication of the ART 
Success Rates Report.2 Thus, the report describing ART procedures performed in 2009 is 
published at the end of 2011. To improve the timeliness of publishing clinic-specific success 
rates, the CDC plans to release these rates in advance of the aggregate national data 
beginning in 2012. Outreach to the few nonreporting ART clinics, which tend to be smaller 
and may not belong to the relevant professional societies, could improve completeness of 
the NASS.2 The quality of reported data can be further improved by prospective reporting, 
ie, initial reporting of ART procedure (cycle start date and patient’s demographic 
information) within 4 days of procedure initiation, and complete reporting when the 
outcome of the procedure is known. All member-clinics of the Society for Assisted 
Reproductive Technology are now required to report prospectively.3 Extension of 
prospective reporting to non–member-clinics (approximately 15% of ART clinics) could 
further improve data quality and accountability.
The growing population of ART-conceived children and the contribution of ART to multiple 
and preterm births makes ART an important public health issue, which the NASS can help 
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to address.4 However, the NASS only contains limited pregnancy outcome information. 
Linking ART surveillance data with other surveillance systems could be an efficient 
approach to monitor long-term outcomes of ART. In collaboration with the health 
departments of Massachusetts, Michigan, and Florida, NASS data are being linked to vital 
records, hospital discharge data, birth defects’ registries, cancer registries, and other 
surveillance systems.5 This project, the States Monitoring ART Collaborative, provides an 
opportunity to establish state-based patient-focused (vs cycle-focused) public health 
surveillance of ART, infertility, and related issues.
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